What is Biogen's derivative liability, current?

Biogen (BIIB) reported derivative liability, current of $38.20M in Q1 2026.

What does derivative liability, current mean?

The value of derivative contracts expected to be settled within one year that are currently unfavorable to the company.

Derivative Liability, Current

Biogen Derivative Liability, Current decreased by 32.6% to $38.20M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalLower is better

VolatilityVolatile

First reportedQ4 2020

Last reportedQ3 2025

How to read this metric

An increase indicates potential near-term cash outflows to settle hedging obligations.

Detailed definition

This represents the fair value of derivative financial instruments that are expected to be settled within the next twelv...

Peer comparison

Monitored by investors to assess short-term cash flow volatility in energy companies.

Metric ID: current_liabilities_derivative_liabilities_current

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$56.70M	$38.20M
QoQ Change	—	-32.6%

Range$38.20M – $56.70M

Frequently Asked Questions

What is Biogen's derivative liability, current?: Biogen (BIIB) reported derivative liability, current of $38.20M in Q1 2026.
What does derivative liability, current mean?: The value of derivative contracts expected to be settled within one year that are currently unfavorable to the company.